Sonendo (SONX) Competitors $0.02 0.00 (0.00%) As of 08/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SONX vs. VRAYQ, AFIB, NMRD, UTRS, MOTS, VIVE, DRTSW, ANZUW, ATAKW, and BBLGWShould you be buying Sonendo stock or one of its competitors? The main competitors of Sonendo include ViewRay (VRAYQ), Acutus Medical (AFIB), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), and Bone Biologics (BBLGW). These companies are all part of the "medical equipment" industry. Sonendo vs. Its Competitors ViewRay Acutus Medical Nemaura Medical Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics ViewRay (NASDAQ:VRAYQ) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability. Do institutionals and insiders have more ownership in VRAYQ or SONX? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, VRAYQ or SONX? ViewRay has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Sonendo has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Is VRAYQ or SONX more profitable? ViewRay has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. ViewRay's return on equity of 0.00% beat Sonendo's return on equity.Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A Sonendo -92.74%-184.01%-68.60% Which has higher earnings & valuation, VRAYQ or SONX? Sonendo has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ASonendo$44.40M0.00-$60.92M-$59.120.00 Does the media prefer VRAYQ or SONX? In the previous week, ViewRay's average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral Sonendo Neutral SummaryViewRay and Sonendo tied by winning 4 of the 8 factors compared between the two stocks. Get Sonendo News Delivered to You Automatically Sign up to receive the latest news and ratings for SONX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SONX vs. The Competition Export to ExcelMetricSonendoDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$9K$9K$5.57B$20.65BDividend YieldN/AN/A4.31%3.66%P/E Ratio0.00N/A29.4329.27Price / Sales0.000.00443.8862.24Price / CashN/AN/A35.8423.31Price / Book0.000.008.084.37Net Income-$60.92M-$60.92M$3.26B$996.36M7 Day PerformanceN/AN/A0.44%0.59%1 Month PerformanceN/AN/A4.82%0.23%1 Year PerformanceN/AN/A30.19%16.71% Sonendo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SONXSonendoN/A$0.02flatN/A-70.2%$9K$44.40M0.00250Upcoming EarningsVRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300AFIBAcutus MedicalN/A$0.00flatN/A-98.1%$15K$7.16M0.00340NMRDNemaura Medical1.1971 of 5 stars$0.00flatN/AN/A$8K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.0474 of 5 starsN/AN/A-99.8%$1K$319K0.0030VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.24+2.6%N/A+39.5%$0.00N/A0.0080Positive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.05-25.0%N/A-8.5%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02+55.7%N/A-60.5%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$15.00+11.1%N/A-75.2%$0.00N/A0.002Positive NewsGap Up Related Companies and Tools Related Companies VRAYQ Alternatives AFIB Alternatives NMRD Alternatives UTRS Alternatives MOTS Alternatives VIVE Alternatives DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SONX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonendo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonendo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
